These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 1772293

  • 1. Determination of oxygen radical production in spondyloarthropathies by whole blood chemiluminescence.
    Ristola M, Leirisalo-Repo M, Repo H.
    Ann Rheum Dis; 1991 Nov; 50(11):782-6. PubMed ID: 1772293
    [Abstract] [Full Text] [Related]

  • 2. Increased oxygen radical production determined by whole blood chemiluminescence in patients with previous Yersinia arthritis.
    Ristola M.
    APMIS; 1990 Feb; 98(2):125-30. PubMed ID: 2302347
    [Abstract] [Full Text] [Related]

  • 3. Oxygen radical production and trapping in subjects with previous Yersinia infection.
    Ristola M, Metsä-Ketelä T, Leirisalo-Repo M, Repo H.
    Inflammation; 1992 Jun; 16(3):273-83. PubMed ID: 1323531
    [Abstract] [Full Text] [Related]

  • 4. Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease.
    Koivuranta-Vaara P, Leirisalo-Repo M, Repo H.
    Ann Rheum Dis; 1987 Apr; 46(4):307-13. PubMed ID: 3592787
    [Abstract] [Full Text] [Related]

  • 5. The phagocyte oxidative metabolism function in ankylosing spondylitis.
    Wendling D, Didier JM, Vuitton DA.
    Rheumatol Int; 1991 Apr; 11(4-5):187-9. PubMed ID: 1664542
    [Abstract] [Full Text] [Related]

  • 6. Whole blood luminol-enhanced chemiluminescence: statistical analysis of the responses of different subjects.
    Ristola M, Repo H.
    J Biolumin Chemilumin; 1990 Apr; 5(3):155-60. PubMed ID: 2220413
    [Abstract] [Full Text] [Related]

  • 7. The oxidative metabolism of circulating phagocytes in ankylosing spondylitis: determination by whole blood chemiluminescence.
    Ho KJ, Chen PQ, Chang CY, Lu FJ.
    Ann Rheum Dis; 2000 May; 59(5):338-41. PubMed ID: 10784514
    [Abstract] [Full Text] [Related]

  • 8. Polymorphonuclear leucocyte function and previous yersinia arthritis: correlation of enhanced superoxide production with late manifestations.
    Repo H, Koivuranta-Vaara P, Leirisalo-Repo M.
    Ann Rheum Dis; 1988 Jun; 47(6):452-7. PubMed ID: 2838004
    [Abstract] [Full Text] [Related]

  • 9. Enhanced inflammatory reactivity in the pathogenesis of spondyloarthropathies.
    Repo H, Ristola M, Leirisalo-Repo M.
    Autoimmunity; 1990 Jun; 7(4):245-54. PubMed ID: 2102768
    [Abstract] [Full Text] [Related]

  • 10. Neutrophil functions, spondylarthropathies and HLA-B27: a study of 43 patients.
    Biasi D, Carletto A, Caramaschi P, Bellavite P, Andrioli G, Caraffi M, Pacor ML, Bambara LM.
    Clin Exp Rheumatol; 1995 Jun; 13(5):623-7. PubMed ID: 8575141
    [Abstract] [Full Text] [Related]

  • 11. Neutrophil function and HLA-B27. Superoxide production and yersinicidal activity of neutrophils from patients with previous yersinia arthritis.
    Repo H, Leirisalo-Repo M, Skurnik M, Tiilikainen A.
    Med Biol; 1984 Jun; 62(2):91-4. PubMed ID: 6088912
    [Abstract] [Full Text] [Related]

  • 12. IgM, IgG, and IgA synthesis in vitro in persons suffering from yersinia arthritis and in patients with ankylosing spondylitis.
    Vuento R, Eskola J, Leino R, Koskimies S, Viander M.
    Ann Rheum Dis; 1984 Apr; 43(2):186-91. PubMed ID: 6370149
    [Abstract] [Full Text] [Related]

  • 13. Enhanced neutrophil migration in vivo HLA B27 positive subjects.
    Koivuranta-Vaara P, Repo H, Leirisalo M, Kiistala U, Osterman T, Vapaatalo H.
    Ann Rheum Dis; 1984 Apr; 43(2):181-5. PubMed ID: 6370148
    [Abstract] [Full Text] [Related]

  • 14. [Reactive Yersinia pseudotuberculosis arthritis with acute hepatic histological involvement disclosing latent ankylosing spondylitis].
    Doury P, Pattin S, Eulry F, Bernard J, Masson C.
    Rev Rhum Mal Osteoartic; 1983 Dec; 50(12):821-3. PubMed ID: 6607507
    [No Abstract] [Full Text] [Related]

  • 15. Effects of tetracaine and bupivacaine on chemiluminescence generated by formyl-methionyl-leucyl-phenylalanine-stimulated human leukocytes and cell-free systems.
    Günaydin B, Demiryürek AT.
    Int Immunopharmacol; 2003 May; 3(5):757-64. PubMed ID: 12757744
    [Abstract] [Full Text] [Related]

  • 16. Absence of lymphotoxic antibodies in patients with Yersinia-induced arthritis, Reiter's syndrome and ankylosing spondylitis.
    Kono DH, Park MS, Yu DT, Granfors K, Toivanen A.
    Clin Exp Rheumatol; 1984 May; 2(4):303-7. PubMed ID: 6335862
    [Abstract] [Full Text] [Related]

  • 17. Intestinal permeability in patients with yersinia triggered reactive arthritis.
    Lahesmaa-Rantala R, Magnusson KE, Granfors K, Leino R, Sundqvist T, Toivanen A.
    Ann Rheum Dis; 1991 Feb; 50(2):91-4. PubMed ID: 1998397
    [Abstract] [Full Text] [Related]

  • 18. Luminol-enhanced chemiluminescence of whole blood. Statistical analysis, and comparison of the responses of different subjects.
    Ristola M, Repo H.
    APMIS; 1989 Jun; 97(6):503-12. PubMed ID: 2736103
    [Abstract] [Full Text] [Related]

  • 19. Release of oxygen radicals by articular chondrocytes: a study of luminol-dependent chemiluminescence and hydrogen peroxide secretion.
    Rathakrishnan C, Tiku K, Raghavan A, Tiku ML.
    J Bone Miner Res; 1992 Oct; 7(10):1139-48. PubMed ID: 1280902
    [Abstract] [Full Text] [Related]

  • 20. [Yersinia enterocolitica, ankylosing spondylitis and HL-A B27].
    Kluin-Nelemans JC, Meuwissen OJ.
    Ned Tijdschr Geneeskd; 1977 Apr 09; 121(15):629-31. PubMed ID: 854105
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.